These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 10660314)
1. A case of acquired iris depigmentation as a possible complication of levobunolol eye drops. Doyle E; Liu C Br J Ophthalmol; 1999 Dec; 83(12):1405-6. PubMed ID: 10660314 [No Abstract] [Full Text] [Related]
2. Drops and falls. Spratt A; Ogunbowale L; Khawaja A; Franks W Age Ageing; 2006 Nov; 35(6):646. PubMed ID: 17047012 [No Abstract] [Full Text] [Related]
3. Allergic contact dermatitis from levobunolol eyedrops. di Lernia V; Albertini G; Bisighini G Contact Dermatitis; 1995 Jul; 33(1):57. PubMed ID: 7493471 [No Abstract] [Full Text] [Related]
4. Allergic contact dermatitis due to levobunolol in an ophthalmic preparation. Hashimoto Y; Aragane Y; Kawada A J Dermatol; 2006 Jul; 33(7):507-9. PubMed ID: 16848829 [No Abstract] [Full Text] [Related]
11. Bradyarrhythmias secondary to topical levobunolol hydrochloride solution. Lin L; Wang Y; Chen Y; Liu M Clin Interv Aging; 2014; 9():1741-5. PubMed ID: 25342892 [TBL] [Abstract][Full Text] [Related]
12. Increased iris pigment in a child due to latanoprost. Brown SM Arch Ophthalmol; 1998 Dec; 116(12):1683-4. PubMed ID: 9869807 [No Abstract] [Full Text] [Related]
13. The effect of once-daily levobunolol on intraocular pressure in normal-tension glaucoma. Inoue K; Ezure T; Wakakura M; Inoue J; Tomita G Jpn J Ophthalmol; 2005; 49(1):58-9. PubMed ID: 15692777 [No Abstract] [Full Text] [Related]